| P2093 | author name string | Gareth J Parry | |
| | Suraj Ashok Muley | |
| P2860 | cites work | Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy | Q24246094 |
| | Cyclosporin A in the treatment of chronic demyelinating polyradiculoneuropathy | Q33588840 |
| | Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisolone | Q34394323 |
| | Multifocal motor neuropathy: clinical and immunological features and response to IVIg in relation to the presence and degree of motor conduction block. | Q35467947 |
| | Efficacy of mycophenolate mofetil in patients with chronic immune demyelinating polyneuropathy | Q35869780 |
| | Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study | Q42638752 |
| | Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. | Q43708051 |
| | Treatment of chronic inflammatory demyelinating polyneuropathy with pulsed oral steroids | Q46253272 |
| | Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study | Q48954233 |
| | Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study | Q49125609 |
| | Intermittent cyclophosphamide with prednisone versus placebo for polyneuropathy with IgM monoclonal gammopathy. | Q53185795 |
| | Rituximab therapy in monoclonal IgM-related neuropathies | Q57904868 |
| | Multifocal motor neuropathy with and without conduction block: A single entity? | Q59243994 |
| | Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force | Q70147600 |
| | Multifocal demyelinating neuropathy with persistent conduction block | Q70680262 |
| | Treatment experience in patients with anti-myelin-associated glycoprotein neuropathy | Q73897239 |
| | High-dose cyclophosphamide without stem-cell rescue for refractory CIDP | Q74365209 |
| | Deterioration of multifocal motor neuropathy after plasma exchange | Q74575154 |
| | Pulse cyclophosphamide therapy in chronic inflammatory demyelinating polyneuropathy | Q77690657 |
| | Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome | Q77758996 |
| | IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using Rituximab | Q77759546 |
| | Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial | Q80246467 |
| | Follow-up study and response to treatment in 23 patients with Lewis-Sumner syndrome | Q80407989 |
| | Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial | Q80454073 |
| | Predictors of response to rituximab in patients with neuropathy and anti-myelin associated glycoprotein immunoglobulin M | Q80470702 |
| | Rituximab stabilizes multifocal motor neuropathy increasingly less responsive to IVIg | Q81134602 |
| | Multifocal motor neuropathy: the diagnostic spectrum and response to treatment | Q81483643 |
| P433 | issue | 3 | |
| P304 | page(s) | 221-227 | |
| P577 | publication date | 2009-05-01 | |
| P1433 | published in | Current treatment options in neurology | Q26842298 |
| P1476 | title | Inflammatory demyelinating neuropathies. | |
| P478 | volume | 11 | |